CN1282592A - Plaster for treating bone diseases - Google Patents
Plaster for treating bone diseases Download PDFInfo
- Publication number
- CN1282592A CN1282592A CN00110671A CN00110671A CN1282592A CN 1282592 A CN1282592 A CN 1282592A CN 00110671 A CN00110671 A CN 00110671A CN 00110671 A CN00110671 A CN 00110671A CN 1282592 A CN1282592 A CN 1282592A
- Authority
- CN
- China
- Prior art keywords
- plaster
- treatment
- bone diseases
- treating bone
- orthopaedic disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A plaster for treating bone diseases including bone tuberculosis, osteomyelitis, rheumatism and theumatoid bone diseases is prepared from 14 Chinese medicinal materials including frankincense, myrrh, Dragon's blood, pearl, rosin, etc., and features high curative effect.
Description
The invention belongs to Chinese patent medicine, more precisely is a kind of plaster for the treatment of orthopaedic disease, is suitable for treating multiple orthopaedic disease.
Orthopaedic disease is a kind of multiple commonly encountered diseases, as bone tuberculosis, and acute and chronic osteomyelitis, rheumatism, orthopaedic disease serious harm human survival health such as rheumatoid.People develop out the medicine of various treatment orthopaedic diseases for this reason, but seek the curative effect height, and the medicine of broad-spectrum treatment orthopaedic disease is still the unremitting pursuit of people.
Given this, the object of the present invention is to provide the plaster of a kind of efficient, wide spectrum, treatment orthopaedic disease easy to use, safe, this plaster is used for the treatment of bone tuberculosis, acute and chronic osteomyelitis, and orthopaedic diseases such as rheumatism, rheumatoid have notable therapeutic effect.
Purpose of the present invention is achieved through the following technical solutions: a kind of plaster for the treatment of orthopaedic disease, make by following weight percentages:
Olibanum 7-9 Myrrha 7-9 Sanguis Draxonis 5-6 Margarita 2-3
Calomelas 2-3 Hydrargyri Oxydum Rubrum 2-3 Aerugo 5-6 Herba Inulae cappae 5-6
Lithargyrum 5-6 Plumbum preparatium 5-6 Vermilion 5-6 Colophonium 16-17
Semen Ricini 26-28 Venenum Bufonis 0.1-0.2
The Chinese medicine plaster preparation process is produced routinely, every pair 10 gram.
Embodiment
Olibanum 80g Myrrha 80g Sanguis Draxonis 54g Margarita 27g
Calomelas 27g Hydrargyri Oxydum Rubrum 27g Aerugo 54g Herba Inulae cappae 54g
Lithargyrum 54g Plumbum preparatium 54g Vermilion 54g Colophonium 170g
Semen Ricini 270g Venenum Bufonis 1g
The Chinese medicine plaster preparation process is manufactured plaster routinely, every pair of 10g.
Plaster of the present invention adopts Chinese medicine to manufacture, and compatibility is original, have to remove the rotten and let fresh grow, and blood circulation promoting and blood stasis dispelling, toxin expelling is let out turbid, the function of revisal symplectic bone, through clinical 213 routine orthopaedic disease patient's externals, the curative effect wide spectrum, evident in efficacy, easy to use, safe.
Case 1. is closed 41 years old Lang Jiatun village, poplar woods township of English pendant woman, is diagnosed as bone tuberculosis through the city tuberculosis hospital, the recovery from illness in 4 months of this plaster of clinical use.
Case 2. Nie Longxing man Shenyang City 95 years feet in Shenhe District literature and art road are trike disease, and 463 hospitals are diagnosed as acute osteomyelitis through Shenyang, 2 sick recoveries from illness of first quarter moon behind the use plaster.
The report key word is looked in the 213 routine clinical sights of plaster treatment orthopaedic disease: plaster, medicine for external use, treatment orthopaedic disease
Summary: purpose: understand the plaster clinical therapeutic efficacy
Method: adopt the stochastic sampling double-blind method to see and look into therapeutic effect and the safety thereof of plaster to 213 routine orthopedics patients.
Do not find any pair of effect in clinical.
Conclusion: the plaster treatment effect is good, and safety is good, and is easy to use.
1, materials and methods
1,1 object of observation medication same period patient, 213 sides, age 18-75 year, bone tuberculosis 60 examples wherein, acute and chronic osteomyelitis 68 examples, rheumatism 48 examples, rheumatoid 37 examples.
1,2 therapeutic regimens
Full group patient is divided into treatment at random by double-blind method and organizes 213 examples.The treatment group gives plaster clinical outer clothes treatment, 1 pair of subsides affected part on the 3rd.
1,3 sees checking method
All all write down medical history before every routine patient, sign, diagnosis, painful area and character and relevant physics, physiology inspection.
1,4 therapeutic effect are observed
Patient 30 days was a course of treatment to paste medicine, bone tuberculosis wherein, and the acute and chronic osteomyelitis treatment phase is three courses of treatment, rheumatism, rheumatoid are a course of treatment.
Criterion of therapeutical effect:
A, invalid: the treatment back does not have change with treatment state of an illness symptom.
B, effective: treatment back state of an illness sign has improvement.
C, produce effects: treatment back state of an illness sign has clear improvement.
D, recovery from illness: treatment back disease all disappears, and reaches the clinical cure standard.
1,5 treatments are analyzed
All clinical datas behind finishing analysis with the treatment group invalid, effectively, produce effects, four standards of fully recover are judged comparison, look into the significance of its difference by the statistical procedures sight.
2 results
2,1 curative effect
This group 213 examples are used plaster treatment orthopaedics patient efficacy result
Table one
213 routine patient treatment curative effect statistical table tables two
Diagnosis | The example number | Curative effect | ||||
Invalid | Effectively | Produce effects | Recovery from illness | |||
Bone tuberculosis | ???60 | ???49 | ???11 | |||
Acute osteomyelitis | ???38 | ???15 | ???23 | |||
Chronic osteomyelitis | ???30 | ???19 | ???11 | |||
Rheumatism | ???48 | ???28 | ???20 | |||
Rheumatoid | ???37 | ???28 | ????9 |
Group | The example number | Curative effect | ||||
Invalid % | Effective % | Produce effects % | Recovery from illness % | |||
The plaster treatment group | ?213 | ???65 | ???35 |
The scientific research statistical procedures
P<0.01
2,2 toxic and side effects
213 examples are used none example of plaster patient and toxic and side effects such as discomfort occurred.Experimental check hematuria, the just all no abnormal change of routine, liver, renal function.Pointing out plaster thus is safety medicine for external use without any side effects.
Claims (1)
1, a kind of plaster for the treatment of orthopaedic disease is characterized in that: made by following weight percentages:
Olibanum 7-9 Myrrha 7-9 Sanguis Draxonis 5-6 Margarita 2-3
Calomelas 2-3 Hydrargyri Oxydum Rubrum 2-3 Aerugo 5-6 Herba Inulae cappae 5-6
Lithargyrum 5-6 Plumbum preparatium 5-6 Vermilion 5-6 Colophonium 16-17
Semen Ricini 26-28 Venenum Bufonis 0.1-0.2
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB001106716A CN1147308C (en) | 2000-07-18 | 2000-07-18 | Plaster for treating bone diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB001106716A CN1147308C (en) | 2000-07-18 | 2000-07-18 | Plaster for treating bone diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1282592A true CN1282592A (en) | 2001-02-07 |
CN1147308C CN1147308C (en) | 2004-04-28 |
Family
ID=4580650
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB001106716A Expired - Fee Related CN1147308C (en) | 2000-07-18 | 2000-07-18 | Plaster for treating bone diseases |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1147308C (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102327300A (en) * | 2011-09-26 | 2012-01-25 | 郭志斌 | External traditional Chinese medicine ointment for treating bone tuberculosis and lymphoid tuberculosis |
CN101574448B (en) * | 2009-06-23 | 2012-05-09 | 杨昕辰 | Traditional Chinese medicine combination suitable for curing hyperosteogeny by external administration and preparation method thereof |
CN103263526A (en) * | 2013-04-17 | 2013-08-28 | 明传扬 | Tumor, bone spurs, hyperplasia and blood stasis dispersing paste |
CN105267827A (en) * | 2015-11-20 | 2016-01-27 | 常方峰 | External application traditional Chinese medicine for treating orthopedic diseases |
CN107998254A (en) * | 2017-12-22 | 2018-05-08 | 蒋志鹏 | Ointment |
-
2000
- 2000-07-18 CN CNB001106716A patent/CN1147308C/en not_active Expired - Fee Related
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101574448B (en) * | 2009-06-23 | 2012-05-09 | 杨昕辰 | Traditional Chinese medicine combination suitable for curing hyperosteogeny by external administration and preparation method thereof |
CN102327300A (en) * | 2011-09-26 | 2012-01-25 | 郭志斌 | External traditional Chinese medicine ointment for treating bone tuberculosis and lymphoid tuberculosis |
CN102327300B (en) * | 2011-09-26 | 2013-04-24 | 郭志斌 | External traditional Chinese medicine ointment for treating bone tuberculosis and lymphoid tuberculosis |
CN103263526A (en) * | 2013-04-17 | 2013-08-28 | 明传扬 | Tumor, bone spurs, hyperplasia and blood stasis dispersing paste |
CN105267827A (en) * | 2015-11-20 | 2016-01-27 | 常方峰 | External application traditional Chinese medicine for treating orthopedic diseases |
CN107998254A (en) * | 2017-12-22 | 2018-05-08 | 蒋志鹏 | Ointment |
Also Published As
Publication number | Publication date |
---|---|
CN1147308C (en) | 2004-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1739638A (en) | Medicine for treating dermatosis and its prepn | |
CN1147308C (en) | Plaster for treating bone diseases | |
CN1136003C (en) | Exterior-applied ointment for treating dermatitis | |
CN1785335A (en) | Pure Chinese medicinal preparation for external treating burn and scald | |
CN1100945A (en) | Broad spectrum detoxicating medicine for curing snakebite | |
CN1233405C (en) | Angitis treating medicine | |
CN1302800C (en) | Chinese traditional medicine preparation for curing gastric ulcer | |
CN1120721C (en) | Exterior-applied ointment for treating piles | |
CN1175841C (en) | Chinese medicine for treating tinea and antipruritic | |
CN1095371C (en) | Capsule for treating bone diseaes | |
CN103223022B (en) | Medicine for treating fracture | |
CN1186068C (en) | Externally applied Chinese medicine with functions of diminishing inflammation, promoting granulation, stopping itch and stopping pain and its prepn process | |
CN1686414A (en) | Wound dispelling swell dispersing tincture and its preparation method | |
CN1086297C (en) | A Chinese medicinal pill for treating gynecological diseases | |
CN1163258C (en) | Medicine composite and its preparation | |
CN1254255C (en) | Oral liquor for curing cerebral hemorrhage and its preparation method by using leach | |
WO2024032710A1 (en) | Method against snake envenomation | |
CN1456178A (en) | External applied medicine for curing burn and preparing method thereof | |
CN1745839A (en) | Compound Chinese medicine for gout | |
CN1247222C (en) | Pharmaceutical composition for treating AlDS | |
CN1839974A (en) | Medicine composition for treating rheumatoid disease and method for preparing the same | |
Gu et al. | Clinical progress in the treatment of severe acute pancreatitis with integrative Chinese and Western medicine | |
CN101049313A (en) | New usage for treating chronic hepatitis by using injection of Prostaglandins microsphere carrier | |
CN1569117A (en) | Medicine for treating piles | |
CN1720968A (en) | Medicine for treating cerebrovascular diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |